ITRN vs ANRO
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
ITRN · Ituran Location & Control$49.76 ▼ 0.34%
ANRO · Alto Neuroscience$25.16 ▲ 15.04%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- ITRN +38.6%
- ANRO +97.5%
Head to head
| Metric | ITRN | ANRO |
|---|---|---|
| Price | $49.76 | $25.16 |
| Change today | ▼ 0.34% | ▲ 15.04% |
| Market cap | $987.02M | $987.33M |
| Return, 3 months | -3.0% | -11.1% |
| Return, year to date | +21.4% | +41.3% |
| Return, 1 year | +37.5% | +117.8% |
| P/E (TTM) | 15.4 | – |
| P/B | 4.5 | 4.5 |
| P/E percentile vs own 5y | 85th | 23rd |
| Dividend yield | 6.03% | – |
| Revenue growth (YoY, latest qtr) | +20.7% | – |
| Net profit growth (YoY) | +29.5% | -56.1% |
| Gross margin | 50.0% | – |
| Operating margin | 22.0% | – |
| Net margin | 16.3% | – |
| Return on equity | 30.2% | -49.2% |
| Analyst target vs. price | +60.8% | +81.5% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 40 | 55 |
| 30-day volatility | 25.2% | 68.9% |
| Max drawdown, 1 year | -23.8% | -40.7% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- ANRO is the largest of the group by market value.
- ANRO has returned the most over the past year.
- ITRN has been the calmest stock over the last 30 days.